Geistlich Pharma’s Chondro-Gide® articular cartilage cover was granted an FDA Breakthrough Device Designation. Chondro-Gide collagen membrane is used in a single-step cartilage repair technique.
Chondro-Gide Articular Cartilage Cover
The highly purified collagen membrane leverages the body’s own healing potential. It is used with bone marrow stimulation to treat defects.
More than 10 years of clinical success in Europe have shown the product to be a cost-effective single surgery treatment for repairing lesions with bone marrow stimulation techniques.
“The device is versatile and can be used in minimally invasive procedures where indicated,” said Carrie Hartill, Business Unit Director for Geistlich Surgery. “Cost effective, single surgery cartilage repair devices are not currently available in the USA, and Chondro-Gide® will fill this unmet clinical need.”
Geistlich Pharma's Chondro-Gide® articular cartilage cover was granted an FDA Breakthrough Device Designation. Chondro-Gide collagen membrane is used in a single-step cartilage repair technique.
The highly purified collagen membrane leverages the body’s own healing potential. It is used with bone marrow stimulation to treat defects. ...
Geistlich Pharma’s Chondro-Gide® articular cartilage cover was granted an FDA Breakthrough Device Designation. Chondro-Gide collagen membrane is used in a single-step cartilage repair technique.
Chondro-Gide Articular Cartilage Cover
The highly purified collagen membrane leverages the body’s own healing potential. It is used with bone marrow stimulation to treat defects.
More than 10 years of clinical success in Europe have shown the product to be a cost-effective single surgery treatment for repairing lesions with bone marrow stimulation techniques.
“The device is versatile and can be used in minimally invasive procedures where indicated,” said Carrie Hartill, Business Unit Director for Geistlich Surgery. “Cost effective, single surgery cartilage repair devices are not currently available in the USA, and Chondro-Gide® will fill this unmet clinical need.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
